MUTYH-Associated Polyposis Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is MUTYH-Associated Polyposis?
MUTYH-Associated Polyposis (MAP) is an inherited colorectal polyposis syndrome caused by pathogenic variants in both copies of the MUTYH gene. The condition can lead to multiple adenomatous polyps in the colon and rectum and substantially increases the risk of colorectal cancer. MAP may also involve polyps or cancers in other organs, including the duodenum.
Some individuals may develop colorectal cancer even when they have relatively few colorectal polyps, making appropriate genetic assessment and surveillance important.
What is the Importance of Timely Treatment?
Timely diagnosis and surveillance are important because adenomatous polyps associated with MAP can gradually progress to colorectal cancer. Without appropriate surveillance, the lifetime risk of colorectal cancer can be very high. Regular colonoscopy allows doctors to identify and remove precancerous polyps before they progress. When the number or size of polyps becomes difficult to control endoscopically, colorectal surgery may be considered to reduce cancer risk.
What are the Common Symptoms of MUTYH-Associated Polyposis?
- Multiple adenomatous colorectal polyps
- Rectal bleeding or blood in the stool
- Abdominal pain or discomfort
- Bloating
- Changes in bowel habits
- Diarrhea
- Iron-deficiency anemia
- Unexplained weight loss
- Fatigue related to anemia or cancer
- Colorectal cancer in some individuals
- Duodenal or other gastrointestinal polyps
Causes and Risk Factors of MUTYH-Associated Polyposis
Causes
- MAP occurs because of pathogenic variants in both copies of the MUTYH gene, which repairs oxidative DNA damage. When both copies are affected, DNA repair may become less effective, allowing abnormal cells and adenomatous polyps to develop.
- MAP is inherited in an autosomal recessive pattern, meaning an affected individual generally inherits one pathogenic MUTYH variant from each parent.
Risk Factors
- Having pathogenic MUTYH variants in both gene copies
- Having parents who are carriers of a MUTYH pathogenic variant
- A family history of MAP or colorectal cancer
- A personal history of multiple adenomatous colorectal polyps
- Early-onset colorectal cancer
- Having a sibling with confirmed MAP
Latest Research and Technologies in the Treatment of MUTYH-Associated Polyposis in India
- Current management of MAP focuses on genetic diagnosis, regular colonoscopic surveillance, advanced polyp removal, and timely colorectal surgery when endoscopic management is no longer sufficient. Germline genetic testing, including multigene panels, can help distinguish MAP from other hereditary colorectal cancer syndromes. High-quality colonoscopy with polypectomy remains central to cancer prevention, while advanced endoscopic techniques can assist in managing suitable adenomas. For patients with extensive polyposis, minimally invasive colorectal surgery may be considered.
Treatment options for MUTYH-Associated Polyposis
Colonoscopic Surveillance and Polyp Removal: Regular high-quality colonoscopy allows doctors to identify and remove adenomatous polyps before they progress. Surveillance intervals are generally based on individual polyp burden and clinical findings.
Preventive Colorectal Surgery: Colectomy may be considered when the number, size, or distribution of polyps makes endoscopic management inadequate, or when colorectal cancer or significant symptoms are present.
Colectomy with Ileorectal Anastomosis: In selected patients, the colon may be removed while preserving the rectum, with the small intestine connected to the remaining rectum. Continued endoscopic surveillance of the rectum is required after surgery.
Proctocolectomy with Ileal Pouch-Anal Anastomosis: When there is extensive rectal polyposis, removal of both the colon and rectum may be considered, with creation of an ileal pouch to maintain bowel continuity.
Management of Upper Gastrointestinal and Other Manifestations: Upper GI endoscopy can identify gastric, duodenal, or periampullary adenomas. Selected lesions may be removed endoscopically, while thyroid or other abnormalities may require specialist evaluation.
- Clinical assessment:
- Colonoscopy and Polyp Evaluation: Colonoscopy helps identify and assess colorectal polyps based on their number, size, location, and appearance. Clinicians may excise suspicious or removable polyps for further evaluation.
- Histopathology and Genetic Testing: Doctors examine removed polyps under a microscope to confirm their type. Germline MUTYH genetic testing can confirm MAP, and multigene panels may be considered when other hereditary syndromes are suspected.
- Personal and Family History: Doctors review the patient's history of colorectal polyps or cancer and assess family history for hereditary colorectal conditions. This helps determine whether genetic counselling and family testing are needed.
- Blood Tests and Upper GI Evaluation: A complete blood count and iron studies may identify anemia caused by gastrointestinal blood loss. Upper gastrointestinal endoscopy can assess the stomach, duodenum, and ampulla for associated polyps.
- Genetic Counselling and Family Assessment: Genetic counselling helps patients understand MAP, its autosomal recessive inheritance, and implications for relatives. At-risk family members may be offered genetic testing and appropriate surveillance.
- Imaging Tests:
- Thyroid ultrasound: May be considered to evaluate or monitor thyroid abnormalities.
- CT or MRI: May be used when complications, colorectal cancer, or other associated tumors require further assessment.
- CT or MRI of the abdomen and pelvis: May be performed for staging when colorectal cancer is diagnosed.
- Other targeted imaging: May be recommended when symptoms or examination findings suggest disease outside the gastrointestinal tract.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support MUTYH-Associated Polyposis patients in India. These services include:
- Postoperative rehabilitation: Gradual physical activity and recovery support after abdominal or colorectal surgery.
- Nutritional support: Dietary guidance following colectomy or other gastrointestinal procedures.
- Bowel-function management: Education and support for changes in bowel habits following colorectal surgery.
- Cancer rehabilitation: Exercise, nutrition, fatigue management, and psychological support when colorectal cancer treatment is required.
- There is no medicine that corrects the inherited MUTYH variants or completely eliminates the need for colorectal surveillance. Medicines may also be used to manage symptoms, iron-deficiency anemia, postoperative complications, or colorectal cancer when present. Any chemoprevention or cancer-directed treatment should be selected by a specialist according to the patient's individual risk and clinical findings.
Instantly Connect with our Specialists
Hospitals for MUTYH-Associated Polyposis in India
Fortis Hospital
Mohali, India
Fortis Hospital, Mohali, is a leading 400+ bed tertiary care hospital across 8.22 acres, accredited by JCI, NABH, and NABL, offering 42 specialties. The hospital excels in Cardiac Sciences, Oncology, Neurosciences, Orthopaedics, Robotic Surgery, and Transplants. Fortis Cancer Institute provides advanced cancer care with robotic surgery, LINAC, PET-CT, and a multidisciplinary Tumor Board. The Cardiac Centre features 3 high-end cath labs, heart transplants, and expert cardiologists. Neurosciences and Orthopaedics Centres offer advanced brain, spine, joint, and trauma care. Fortis Paalna ensures world-class maternity and neonatal services, including high-risk pregnancy management and stem cell collection, making it a top healthcare destination in North India.
Fortis Flt. Lt. Rajan Dhall Hospital
Delhi, India
Fortis Hospital, Vasant Kunj, New Delhi, established in 2006, is a leading multi-super specialty hospital with over 18 years of excellence. It has treated more than 2 million patients across 40 specialties and performed 8,500+ complex GI surgeries, 9,300+ joint replacements, 3,600+ neurosurgeries, 1,400+ kidney transplants, and 10,000+ high-risk deliveries. The hospital offers advanced robotic surgeries and specialized clinics, including Asthma & Allergy, Kidney Stone, Obesity, Sports Injury, and Sahajini (Menopause Clinic). Accredited by NABH and NABL, it has earned awards from AHPI, CII, and Newsweek’s “World’s Best Hospitals” (2022–2025), reflecting excellence in technology, expertise, and compassionate patient care.
Fortis Escorts Heart Institute, Okhla
Delhi, India
Fortis Escorts Heart Institute, located in New Delhi, was founded in 1988 and is a JCI-accredited cardiac care centre, as well as the largest private heart hospital in the Asia-Pacific region. The hospital has 285 beds, five cath labs, state-of-the-art ICUs, and NABL-accredited labs and offers advanced cardiac care surgery 24?7. The hospital also provides advanced cardiac treatment, but is particularly well-known for heart transplants as well as minimally invasive cardiac surgery and paediatric cardiology. The hospital offers world-class facilities and patient-centric services, providing comprehensive support to all international patients.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for MUTYH-Associated Polyposis Treatment?
- Experienced Gastrointestinal Specialists: India has gastroenterologists, colorectal surgeons, genetic specialists, oncologists, pathologists, and other professionals who can help manage hereditary colorectal polyposis.
- Advanced Endoscopic and Diagnostic Facilities: Specialised centres may provide high-quality colonoscopy, advanced polyp removal, upper GI endoscopy, genetic testing, pathology, and imaging for comprehensive disease assessment.
- Minimally Invasive Colorectal Surgery: Patients requiring surgery may have access to laparoscopic and robotic colorectal procedures, depending on their clinical condition and the expertise available at the selected centre.
- Multidisciplinary Cancer and Genetic Care: Patients can receive coordinated care involving gastroenterology, colorectal surgery, genetics, oncology, radiology, pathology, nutrition, and other specialities, as needed.
- International Patient Support: Many major Indian hospitals provide international patient services that can assist with specialist consultations, diagnostic coordination, treatment planning, accommodation, travel arrangements, and postoperative follow-up.